On a path to recovery; 7 mid-cap pharma stocks with an upside potential up to 47 %After the covid tailwinds got over, pharma stocks witnessed a phase of under-performance. However as the markets get jittery, select pharma...
02 Mar, 2023, 01.04 PM IST
Defensive Bets: 4 midcaps from pharma sector with ‘Buy’ & ‘Strong Buy’ ratings have upside potential of up to 31%As NIFTY gets even more volatile, there are some sectors which are traditionally considered defensive and they tend to get attention when m...
07 Feb, 2023, 02.46 PM IST
Add FDC, target Rs 180: Centrum BrokingFDC is a smallcap company, operating in pharmaceuticals and health care sector.
06 Aug, 2019, 11.52 AM IST